Overcoming bortezomib resistance in human B cells by anti-CD20/rituximab-mediated complement-dependent cytotoxicity and epoxyketone-based irreversible proteasome inhibitors
通过抗 CD20/利妥昔单抗介导的补体依赖性细胞毒性和基于环氧酮的不可逆蛋白酶体抑制剂克服人类 B 细胞对硼替佐米的耐药性
期刊:Experimental Hematology & Oncology
影响因子:9.4
doi:10.1186/2162-3619-2-2
Sue Ellen Verbrugge, Marjon Al, Yehuda G Assaraf, Denise Niewerth, Johan van Meerloo, Jacqueline Cloos, Michael van der Veer, George L Scheffer, Godefridus J Peters, Elena T Chan, Janet L Anderl, Christopher J Kirk, Sonja Zweegman, Ben Ac Dijkmans, Willem F Lems, Rik J Scheper, Tanja D de Gruijl, Ge
细胞生物学
B细胞
FCM
IF
IHC-P
WB
Human